Ligand validation:8FYV

SER: SERINE

SER is a Ligand Of Interest in 8FYV designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8FYV_SER_A_203	84%	35%	0.101	0.964	0.99	1.55	1	2	0	0	100%	1
8FYV_SER_C_204	80%	36%	0.104	0.953	1	1.52	1	2	0	0	100%	1
8FYV_SER_B_207	66%	36%	0.111	0.914	0.96	1.56	1	2	0	0	100%	1
8FYV_SER_E_202	61%	35%	0.158	0.947	0.99	1.56	1	2	0	0	100%	1
8FYV_SER_D_204	54%	36%	0.151	0.917	0.97	1.53	1	2	0	0	100%	1
8VL8_SER_D_204	85%	46%	0.096	0.962	0.89	1.2	-	-	1	0	100%	1
4IY7_SER_B_401	98%	33%	0.054	0.975	1.09	1.53	-	1	0	0	100%	1
4YJ5_SER_B_603	96%	43%	0.073	0.984	0.87	1.31	-	1	1	0	100%	1
3QJX_SER_A_900	95%	38%	0.084	0.988	1.16	1.27	1	1	0	0	100%	1
1UBS_SER_B_398	94%	20%	0.08	0.979	0.94	2.43	-	1	0	0	100%	1
4YKP_SER_A_302	93%	39%	0.089	0.983	1.06	1.31	1	1	7	0	100%	0.33

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.